Hamilton Thorne CEO and leadership

Chief Executive Officer and President; Mr. Wolf is a senior level executive with over 20 years of success in solving complex business issues and building shareholder value in both public and private companies. Previously, David was a member of the founding management team of Elcom International, Inc. (NASDAQ), where he played a key role in growing the business to $800 million in revenues in four years and orchestrating Elcom's successful IPO. As President of Elcom Systems, David transformed an internal development organization into a full-fledged software development, marketing and services company that successfully implemented electronic commerce systems for companies around the world. Prior to Elcom, David was Chief Operating Officer of JWP Information Services, a subsidiary of JWP Inc. (NYSE) where he built the operational infrastructure to support its growth from $250 million to $1.4 billion in sales , and President and COO of NEECO, Inc. (NASDAQ), a $250 million business IT distribution and services business purchased by JWP.

Diarmaid Douglas-Hamilton are a Board Member at Hamilton Thorne Inc, Sr VP:Research & Dev/CTO/Secy at Hamilton Thorne Inc, and Co-Founder at Hamilton Thorne Inc. They attended University of Oxford and Harvard University.

Chairman of the Board. Meg Spencer is CEO and President of Hamilton Biovet, Inc., a supplier of large and small animal breeding, diagnostic and therapeutic products. Previously, she served as Chief Strategic Advisor to the Corporation and HT Inc. Prior to that, she was Chief Executive Officer of HT Inc. from its founding in 1997 to September 2011 and Chief Executive Officer of the Corporation from October 2009 to September 2011. Ms. Spencer founded two previous companies, taking each from start-up to global market leadership in their respective sectors. Hamilton Equine Systems, Inc., a high tech veterinary products company, was successfully sold at an attractive return on investment for its investors. Hamilton-Thorne Research offered reproductive toxicology testing systems for the study of the effects of chemicals, pesticides and prescription drugs on human and animal reproduction.

Vice President of Finance and Chief Financial Officer; Mr. Bruns brings over 25 years of financial management experience in mid-sized organizations, most recently serving as CFO of Dover Saddlery Inc. (NASDAQ: DOVR) where he played a key role in Dover's successful $27 million IPO in 2005. In his role as CFO of Hamilton Thorne, Mr. Bruns will be responsible for the Company's financial management and control functions, as well as providing strategic support in the business planning, and corporate development of the Company. Prior to joining Dover, Mr. Bruns served as Vice President of Finance for CPS Direct, a communications marketing company and was the Controller for Northeast Mobile Communications, a specialty retailer. Education: Simpson College, B.A., Certified Public Accountant (CPA).

Diarmaid Douglas-Hamilton are a Board Member at Hamilton Thorne Inc, Sr VP:Research & Dev/CTO/Secy at Hamilton Thorne Inc, and Co-Founder at Hamilton Thorne Inc. They attended University of Oxford and Harvard University.

Chairman of the Board. Meg Spencer is CEO and President of Hamilton Biovet, Inc., a supplier of large and small animal breeding, diagnostic and therapeutic products. Previously, she served as Chief Strategic Advisor to the Corporation and HT Inc. Prior to that, she was Chief Executive Officer of HT Inc. from its founding in 1997 to September 2011 and Chief Executive Officer of the Corporation from October 2009 to September 2011. Ms. Spencer founded two previous companies, taking each from start-up to global market leadership in their respective sectors. Hamilton Equine Systems, Inc., a high tech veterinary products company, was successfully sold at an attractive return on investment for its investors. Hamilton-Thorne Research offered reproductive toxicology testing systems for the study of the effects of chemicals, pesticides and prescription drugs on human and animal reproduction.

Chairman of the Board. Meg Spencer is CEO and President of Hamilton Biovet, Inc., a supplier of large and small animal breeding, diagnostic and therapeutic products. Previously, she served as Chief Strategic Advisor to the Corporation and HT Inc. Prior to that, she was Chief Executive Officer of HT Inc. from its founding in 1997 to September 2011 and Chief Executive Officer of the Corporation from October 2009 to September 2011. Ms. Spencer founded two previous companies, taking each from start-up to global market leadership in their respective sectors. Hamilton Equine Systems, Inc., a high tech veterinary products company, was successfully sold at an attractive return on investment for its investors. Hamilton-Thorne Research offered reproductive toxicology testing systems for the study of the effects of chemicals, pesticides and prescription drugs on human and animal reproduction.